American College of Nuclear Medicine (ACNM) 2022 ACNM Annual Meeting Abstracts
Clinical Nuclear Medicine. Conference: Annual Meeting of the American College of Nuclear Medicine, ACNM
; 48(5), 2022.
Article
Dans Anglais
| EMBASE | ID: covidwho-2321637
ABSTRACT
The proceedings contain 91 papers. The topics discussed include the new approach of COVID-19 patients with deteriorating respiratory functions using perfusion SPECT/CT imaging;increasing interest in nuclear medicine evaluation of an educational workshop;cost-benefit analysis recommends further utilization of cardiac PET/MR for sarcoidosis evaluation;development of a nomogram model for predicting the recurrence of differentiated thyroid carcinoma patients based on a thyroid cancer database from a tertiary hospital in China;multi-center validation of radiomic models in new data using ComBat-based harmonization of features;bone scan with Tc99m-MDP, the missing link in the initial staging of muscle-invasive bladder carcinoma;and comparison of absorbed doses to kidneys calculated employing three time points and employing two time points in neuroendocrine patients undergoing Lu-177 DOTATATE therapy using planar images.
adult; bone scintiscanning; cancer patient; cancer recurrence; cancer staging; case report; China; clinical article; conference review; coronavirus disease 2019; cost benefit analysis; differentiated thyroid cancer; drug therapy; female; heart; human; kidney; male; muscle invasive bladder cancer; nomogram; nuclear medicine; perfusion; respiratory function; sarcoidosis; single photon emission computed tomography-computed tomography; tertiary care center; validation process; lutetium 177; medronate technetium tc 99m
Collection:
Bases de données des oragnisations internationales
Base de données:
EMBASE
Type d'étude:
Études expérimentales
/
Étude pronostique
langue:
Anglais
Revue:
Clinical Nuclear Medicine. Conference: Annual Meeting of the American College of Nuclear Medicine, ACNM
Année:
2022
Type de document:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS